Rifapentine
Top View
- Statistical Analysis Plan for Clinical Study Report Ac-061A301 / Ac
- PRIFTIN® (Rifapentine) Tablets, for Oral Use ——————————————— CONTRAINDICATIONS ——————————————— Known Hypersensitivity to Any Rifamycin
- Customs Tariff - Schedule
- Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
- Rifamycin O, an Alternative Anti-Mycobacterium Abscessus Agent
- Latent Tuberculosis Infection Treatment Regimens
- TRS958.Indd I 12.04.10 16:01 WHO Library Cataloguing-In-Publication Data
- 12-Dose Regimen for Latent TB Infection
- N-Nitrosamines and Tuberculosis Medicines Rifampicin and Rifapentine
- Quality of Tuberculosis Care Click
- E.Johnson Supplementary
- Handbook of Anti-Tuberculosis Agents
- Antituberculotics and Antileprotics ●Tuberulosis (Consumption; TBC) – WHO Report: 2.109 Infected in 2009 ●Leprosy (Hansen Disese, Hanseniasis) – Approx
- Drug-Induced Hyperpigmentation: Review and Case Series
- Rifapentine Is Not More Active Than Rifampin Against Chronic Tuberculosis in Guinea Pigs
- Pharmaceutical Composition and Kit for Treating Bacterial Infections
- Treating Latent TB Infection – an Update
- Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae